couple listening to doctor from the tablet
Value of biosimilars

Biosimilar medicines offer benefits to patients, healthcare professionals, and funders1

Considerable benefit awaits those patients who will gain access to treatment with biologic medicines in low income countries like South Africa, thanks to the arrival of biosimilar medicines competition.


  • More patients gain access to biologic treatments, and at earlier stages of the therapy cycle
  • Improved access drives better outcomes for patients

Healthcare Professionals1,2

  • Access to a wider spectrum of treatment options
  • Development of value-added services for patients via benefit sharing models
  • Reduced pressure on the prescribers’ budget


  • Creation of a more competitive market with a broader range of cost-effective treatment options
  • Generation of savings across healthcare systems, supporting their sustainability

References: 1. Biosimilar Medicines Group. Biosimilar Medicines Group handbook 2016. Accessed March 2020; 2. Simon-Kucher & Partners. Payers’ price & market access policies supporting a sustainable biosimilar medicines market; 3. Cornes P, Muenzberg M. Pharma Horizon 2016;1:35–38.